Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Preclinical Probes for Neuroimaging Oral I

  • You have access
    [18F]Lansoprazole and [11C]N-methyl lansoprazole: High affinity radiotracers for imaging tau pathology
    Allen Brooks, Melissa Rodnick, Maria Fawaz, Timothy Desmond, Xia Shao, Garrett Carpenter, Carole Quesada, Phillip Sherman and Peter Scott
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 322;
  • You have access
    A novel high affinity F-18 organophosphonate tracer for CNS acetylcholinesterase
    John Gerdes, Shelly James, Syed Ahmed, Yamina Belabassi, Michael Braden, Henry VanBrocklin and Charles Thompson
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 323;
  • You have access
    3-[123I]Iodo-5-(pyridine-2-ylethynyl)benzonitrile ([123I]IPEB): A new SPECT ligand for metabotropic glutamate receptor subtype 5 (mGluR5)
    Kun-Eek Kil, Zhaoda Zhang, Ji-Kyung Choi, Chunyu Gong, Kimmo Jokivarsi, Sreekanth Kura, Alana Ross and Anna-Liisa Brownell
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 325;
  • You have access
    Radiosynthesis and preliminary in vivo studies with [11C]SB216763: The first brain penetrative PET tracer for imaging of glycogen synthase kinase-3 (GSK-3)
    Lei Li, Valentina Ferrari, Young Hong, David Williamson, Tim Fryer and Franklin Aigbirhio
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 324;
  • You have access
    Preclinical evaluation of [18F]MNI-698, a promising F-18 radiotracer for imaging 5HT4 receptors in brain
    Adriana Tavares, Fabien Caille, Olivier Barret, Caroline Papin, Hsiaoju Lee, Thomas Morley, John Seibyl, David Alagille and Gilles Tamagnan
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 320;
  • You have access
    A novel carbon-11 PET radiotracer for imaging VAChT in the brain
    Xiang Zhang, Jinda Fan, Hongjun Jin, Prashanth Padakanti, Kiran Kumar Solingapuram Sai, Robert Mach, Stanley Parsons, Hubert Flores, Joel Perlmutter and Zhude Tu
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 321;
  • You have access
    Radiosynthesis and radiopharmacological evaluation of fluorinated PET radioligands for the 5-HT6 receptors
    Guillaume Becker, Julie Colomb, Thierry Billard and Luc Zimmer
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 326;
SNMMI

© 2025 SNMMI

Powered by HighWire